Month: January 2026

RESTON, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that the Company’s management team will participate in the following investor conferences and events: 28th Annual Needham Growth Conference on January 14 – New York CityLightbridge President and CEO Seth Grae will deliver a presentation on Wednesday, January 14 at 4:30 p.m. Eastern Time. A live webcast of the presentation will be available at: https://wsw.com/webcast/needham148/ltbr/2265900. A replay will also be available on the Company’s YouTube channel at: https://www.youtube.com/@lightbridgecorporation. Global Cleantech Investor Gala & Award Ceremony on January 19 – Davos, SwitzerlandMr. Grae will deliver a presentation titled “The Need for Nuclear”...

Extends Maturity and Reduces Pricing on Unsecured Revolving Credit Facility and Term Loan WEST PALM BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) — LXP Industrial Trust (“LXP”) (NYSE:LXP), a real estate investment trust focused on Class A warehouse and distribution real estate investments, today announced it has closed a $600 million senior unsecured revolving credit facility. The facility amends and restates LXP’s previous unsecured revolving credit facility. The new revolving credit facility matures on January 31, 2030, with the option to extend the maturity for two successive six-month terms or one twelve-month term, at LXP’s discretion, subject to certain conditions. The facility provides for an interest rate of SOFR plus 77.5 basis points, based on LXP’s current consolidated leverage ratio and credit ratings, reduced from...

PITTSBURGH, Pa., Jan. 14, 2026 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the “Company”), an American energy company and the leading innovator in designing, sourcing, manufacturing, and providing zinc-based battery energy storage systems (BESS), today announced the launch of Eos Indensity™—and invites you to experience it first during an unveiling event happening today at 8:30 a.m. ET. Register now and be part of the future of energy storage. Eos Indensity™ is a breakthrough architecture designed to transform how energy storage scales for the real world. It’s engineered with Spatial Intelligence, an innovative system design framework developed by the team at Eos that considers the built, human, and natural environments where power is needed most. Indensity is an architecture...

VANCOUVER, British Columbia, Jan. 14, 2026 (GLOBE NEWSWIRE) — Westhaven Gold Corp. (TSX-V: WHN) (“Westhaven” or the “Company”) announces that materials, including a Management Information Circular (the “Circular”) for the upcoming special meeting of shareholders (the “Meeting”), scheduled for February 17, 2026, have been mailed to shareholders of record as of December 30, 2025 (“Westhaven Shareholders”), and filed under the Company’s profile on Sedar+ (www.sedarplus.ca). At the Meeting, Westhaven Shareholders will consider and, if deemed advisable, pass, with or without variation, an ordinary resolution to approve an earn-in and joint venture agreement between the Company and Dundee Corporation (“Dundee”) pursuant to which the Company will dispose of an up to 60% interest in its Shovelnose Gold Project, Prospect Valley Gold Project,...

-Edie Hofmeister to Succeed Brian Howlett as Chair; Howlett to Remain on Board- TORONTO, Ontario and NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) — Bitfarms Ltd. (NASDAQ/TSX: BITF) (“Bitfarms” or the “Company”), a North American energy and digital infrastructure company, today announced that Edie Hofmeister has been appointed as Chair of the Board of Bitfarms. This appointment supports Bitfarms’ previously announced strategy of redomiciling to the United States. Ms. Hofmeister succeeds Brian Howlett who has served as Director since 2020, and Chairman since 2024. Mr. Howlett will continue to serve as an Independent Director. Ms. Hofmeister brings over two decades of extensive expertise in legal affairs, corporate governance, and business strategy, developed over years in senior leadership roles. As an American business leader, she has...

TORONTO, Jan. 14, 2026 (GLOBE NEWSWIRE) — Premier American Uranium Inc. (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) is pleased to announce completion of the 2025 exploration drilling program at the Cyclone Rim target area of the Company’s wholly-owned Cyclone ISR Uranium Project (“Cyclone” or the “Project”), located in the Great Divide Basin of south-central Wyoming. The exploration program commenced on July 16, 2025, with the objective of further defining sandstone-hosted uranium mineralization that was partially outlined during the Company’s 2024 exploration program. The Project is situated in the vicinity of Ur-Energy Inc.’s Lost Creek ISR uranium mine and Uranium Energy Corp.’s Sweetwater uranium production facility (Figure 2). HighlightsPositive drill results include mineralized zones...

Transformational joint venture with PotisEdge and LONGi establishes domestic BESS manufacturing for utility-scale and C&I markets SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) — NeoVolta Inc. (NASDAQ: NEOV) (“NeoVolta” or the “Company”), a U.S.-based energy technology company delivering scalable energy storage solutions, today announced the formation of NeoVolta Power, LLC, a joint venture established to develop a U.S. battery energy storage system (BESS) manufacturing platform in Pendergrass, Georgia. The launch of domestic manufacturing capacity when complete will represent a transformational expansion of NeoVolta’s business model, positioning the Company to serve the utility-scale and commercial & industrial (C&I) energy storage markets as a U.S. manufacturer. The Georgia facility is designed...

TERRE HAUTE, Ind., Jan. 14, 2026 (GLOBE NEWSWIRE) — Hallador Energy Company (Nasdaq: HNRG), today announced the pricing of an underwritten public offering of 2,777,778 shares of its common stock at a price to the public of $18.00 per share. The total gross proceeds from the offering to Hallador are expected to be approximately $50 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Hallador granted the underwriters a 30-day option to purchase up to an additional 416,666 shares of its common stock. The closing of the offering is expected to occur on or about January 15, 2026, subject to the satisfaction of customary closing conditions. Hallador intends to use the net proceeds from the offering for general corporate purposes, which may include funding certain initial financial...

BENTONVILLE, Ark., Jan. 14, 2026 (GLOBE NEWSWIRE) — Glucose Health, Inc. (OTC: GLUC), a consumer-health company specializing in soluble-fiber nutrition products for metabolic support, today confirmed it has successfully negotiated a Note Settlement Agreement with Board member, Edmund J. Burke. This note, representing a loan to Glucose Health, in the principal amount of $225,000, was originally initiated by Mr. Burke, in August 2024, to provide operating capital to finance Glucose Health, Inc.’s national expansion of GlucoDown, now available in the diabetic care section at more than 1,000 Walgreens pharmacies nationwide. As a result of Mr. Burke’s shareholder friendly agreement, Glucose Health, Inc. now has a debt-free balance sheet. This development further strengthens the Company’s financial position and paves the way for future...

NRX-100 (preservative-free ketamine) has been granted Fast Track Designation by FDA for treatment of suicidal ideation in patients with Depression and Bipolar Depression. Real-world evidence, consistent with FDA guidance, is supplied and generated by Osmind using its nationwide electronic medical records-derived dataset. Previously presented preliminary analysis of a 20,000 patient subset documented rapid resolution of depression and suicidality with initiation of intravenous ketamine. Analyses suggested that clinical response to intravenous ketamine is consistent with prior randomized trial data and compares favorably to currently-approved products. Results from an upcoming analysis of the full 70,000 patient Real World Data set will be presented to the FDA in support of Accelerated Approval.WILMINGTON, Del., Jan. 14, 2026 (GLOBE...